IKT DCF Valuation - Inhibikase Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 1.67 USD Market Closed

Market Cap: $220.5m

	Inhibikase Therapeutics Inc NASDAQ:IKT	US
E	Experian PLC OTC:EXPGF	IE
	Gateley (Holdings) PLC F:5I2	UK
A	Aya Gold & Silver Inc OTC:AYASF	CA
B	Bank CIMB Niaga Tbk PT XBER:NKX	ID
M	Man Wah Holdings Ltd SWB:AAM	HK
R	Re/Max Holdings Inc F:2RM	US
S	Sumitomo Electric Industries Ltd XMUN:SMO	JP
S	Sanmina Corp XMUN:SAYN	US
H	Halliburton Co F:HAL	US

IKT's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.